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Introduction 
Diabetes is the most worldwide common chronic disease, 
according the International Diabetes Federation [1], more than 
32 million citizens living in the European Union have 
diabetes, representing nearly 10% of the population, to which 
we should add equal number of people suffering from 
impaired glucose tolerance. Diabetes prevalence is growing at 
alarming rate worldwide, being of particular relevance the 
type 2 diabetes. Nowadays 285 million people worldwide live 
with diabetes and it is expected that this numbers will increase 
by 20% until 2030 due to obesity and the ageing of the 
population [1].  
This growth leads to an increasing consumption of drugs such 
as oral antidiabetics. Metformin is one of the active principles 
most commonly used for this purpose being among the 
pharmaceuticals with the highest production numbers 
worldwide to treat type 2 diabetes because is cheap, has high 
level of tolerance and when used in the prescribed dosage is 
very secure with minimal side effects. However, in case of 
overdose of metformin upon a ingestion of more than 10 times 
the prescribed dosage, accidentally or on propose, lactic 
acidosis and low blood pressure can occur. Overdoses with 
metformin are relatively uncommon, but may have serious 
consequences, if medical attention is not given on time, it may 
lead to coma and ultimately death Because of its spread use 
another problem must be taken into consideration, which 
needs to be addressed, the occurrence of metformin residues in 
sewage and surface waters due to improper discharge of the 
non-used tablets to regular garbage [2]. This situation is 
becoming a serious problem of environmental pollution and 
public health. 
This paper reports the use of activated carbon produced from 
biomass for the removal of metformin in 2 different settings. 
On one hand, from aqueous solutions and, in another hand, 
from simulated biological fluids (gastric and intestinal) 
conjugated with in vivo testing.   
Experimental 
The activated carbon (AC) samples were produced by carbon 
dioxide activation at 700ºC from vine shoots (V739), and 
800ºC from coffee endocarp (Cf840), esparto grass (E853) and 
Eucalyptus pulp (P827). The last 2 digits stand for the burn-off 
level, in wt%. The experimental details can be seen elsewhere 
[3]. Batch adsorption experiments were carried out in a series 
of Erlenmeyer flasks inserted in a shaking thermostat at 25ºC 
for 120 minutes using 15mL of aqueous solutions of 
metformin, with concentration 1.6 to 550mg/L, and 0.05g of 
AC. Another set of experiments were done at 37ºC using 
simulated body fluids, pepsin omitted, namely intestinal fluid 
(SIF, pH=7.5) and gastric fluid (SGF, pH=1.2). The 
metformin quantification was done by UV-Vis 
spectrophotometry at 233nm. 
Samples P827 and E853 were selected to perform the in vivo 
experiments. This work was done in 16 Wistar rats weighing 
198 to 368 g, which were distributed in three groups. To 
Group 1 the metformin was administered at a dose 600 mg/kg 
that corresponds to approximately 60% LD50. To Group 2 the 
same dose of metformin and activated carbon were 
administered, and finally to the third group only activated 
carbon was given to the animals, in the same dosage as Group 
2. After oral administration the animal behaviour was 
observed. We have analyzed the serum and urine collected 
from the rats in order to study a number of biochemical 
markers, such as amylase, lipase, alanine aminotransferase 
(ALT), aspartate aminotransferase (AST), urea and creatinine. 
The glycaemia of the animals were analysed at pre-determined 
time intervals. 
Results and Discussion 
The principal properties of the ACs can be seen in table 
1. The materials are all basic with point of zero charge (pzc) 
close to 10 but with different porous structure. Although, the 
apparent BET surface area range from 598 to 1122m2g-1 and 
the pore volume (Vs) from 0.31 to 0.46cm3g-1 all ACs are 
essentially microporous, as indicated by the N2 adsorption 
isotherms (not shown here), which are all type I according the 
IUPAC classification. 
Table 1. Textural and chemical characterization of ACs  
BET Alfa s DR 
Sample SBET  
/m2g-1 
Vs  
/cm3g-1 
Sext  
/m2g-1 
V0  
/cm3g-1 
pzc 
E853 1122 0.46 84 0.47 9.52 
P827 649 0.29 25 0.26 10.7 
Cf840 598 0.32 11 0.32 10.2 
V739 708 0.31 49 0.30 9.96 
 
The in vitro metformin maximum adsorption capacity is 
shown in table 2. First of all for the adsorption from aqueous 
solutions, which evaluates the ability of the tested ACs to be 
used in water treatments, we can observe that the highest 
adsorption capacity was observed for samples P827 and E853, 
which reach 30 and 33mg/g, respectively. It seems that the 
adsorption, in this case, is determined by the porous 
development of the samples.  
Regarding the adsorption from simulated body fluids, it 
is visible that the metformin adsorption from SGF (pH=1.2) 
presents a totally different behaviour with adsorption capacity 
 much higher than the other experimental conditions tested. 
The maximum capacity to remove metformin was achieved 
for samples V739, P827 and E853 with approximately 
130mg/g. This high capacity to capture metformin at gastric 
conditions is crucial to prevent the absorption of the drug, 
which occurs mainly at the intestinal tract. The experiments 
done using SIF (pH=7.3) show similar results to those 
performed with aqueous solutions (pH=7.5) probably due to 
the similarity of the pH.  
It is also interesting to observe that at low pH all ACs 
show almost the same adsorption capacity, regardless the pore 
volume or apparent BET area, thus it seems that for SGF 
conditions the driving force for adsorption is the chemical 
interactions between the surface of the ACs and the totally 
ionised metformin molecule.  
Table 2. Maximum adsorption capacity (mg/g) for the in vitro 
study  
Simulated body fluids Sample Aqueous Sol. SIF SGF 
E853 32.8 41.2 132.6 
P827 29.5 23.4 130.2 
Cf840 23.0 11.8 126.7 
V739 15.3 15.8 130.9 
 
The in vivo studies have shown that ACs did not introduce any 
behavioural change on the animal of the group 3. This 
indicates a high biocompatibility of the ACs samples tested 
without any visible toxic effects.  
The animals of group 1 had suffered inflammation and renal 
dysfunction, as indicated by clearance of the creatinine, urea 
and the presence of leucocytes in the urine. On the opposite, 
the animals of group 2 did not shown symptoms of renal 
malfunction, which indicates that the activated carbons 
prevent this to occur by the adsorption of the metformin. The 
glycaemia values of the animals in groups 1, 2 and 3 show 
similar trend after the administration of a glucose bolus at time 
zero, as can be seen in figure 1. 
 
Fig. 1 Glycaemia analyses 
Other biochemical markers such as amylase and lipase, ALT, 
AST showed values for animals in groups 1, 2 and 3 
indicating the non-existence of serious injuries at pancreas, 
hepato-biliary disorders, acute myocardial infarction, 
respectively. 
Conclusions 
1) The ACs tested can be efficiently used to remove 
metformin from water streams, in particular samples E823 and 
P827. 
2) The in vitro adsorption on simulated body fluids has shown 
that adsorption is dependent on the pH and constitution of the 
solution. 
3) The maximum adsorption capacity is achieved at gastric 
conditions, which is fundamental to prevent the drug 
absorption at intestinal tract. 
4) The in vivo studies supported the non-toxic properties of 
ACs and the its capability to prevent the toxic impact of a 
metformin overdose. 
5) It is viable to use the ACs samples for the treatment of drug 
poisoning due to its high biocompatibility and adsorption 
capacity. 
6) If a person was to ingest 10 pills of 850mg of metformin 
and this was to mix with 1L of stomach fluid, a drug 
concentration of 8.5g/L would result, which is in the range of 
an expected overdose. Taking into account the maximum 
adsorption capacity of sample E853 we can estimate a dose of 
140g of activated carbon slurry to treat the person. 
7) Sample E823 showed the best performance in all settings 
studied. 
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